Bicocca Open Archive

Logo unimib boa
ROTA, MATTEO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.664
EU - Europa 4.749
AS - Asia 4.225
SA - Sud America 638
AF - Africa 138
Continente sconosciuto - Info sul continente non disponibili 22
OC - Oceania 14
Totale 19.450
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.427
SG - Singapore 1.586
CN - Cina 1.296
IT - Italia 1.024
RU - Federazione Russa 729
DE - Germania 660
SE - Svezia 650
HK - Hong Kong 641
BR - Brasile 519
IE - Irlanda 471
UA - Ucraina 428
VN - Vietnam 286
GB - Regno Unito 239
CA - Canada 196
FI - Finlandia 131
FR - Francia 102
IN - India 102
ZA - Sudafrica 92
NL - Olanda 66
AT - Austria 63
DK - Danimarca 52
TR - Turchia 51
KR - Corea 49
AR - Argentina 41
JP - Giappone 36
BD - Bangladesh 35
MX - Messico 31
ES - Italia 25
BE - Belgio 22
CO - Colombia 19
IQ - Iraq 18
IR - Iran 18
PL - Polonia 18
EC - Ecuador 16
EU - Europa 16
ID - Indonesia 14
CL - Cile 12
EG - Egitto 11
SA - Arabia Saudita 11
MA - Marocco 10
PK - Pakistan 10
VE - Venezuela 10
AU - Australia 9
CZ - Repubblica Ceca 9
GR - Grecia 9
IL - Israele 9
AE - Emirati Arabi Uniti 8
MY - Malesia 8
CH - Svizzera 7
DZ - Algeria 7
KE - Kenya 7
PE - Perù 7
PY - Paraguay 7
NO - Norvegia 6
RO - Romania 6
TH - Thailandia 6
JO - Giordania 5
NZ - Nuova Zelanda 5
PH - Filippine 5
UY - Uruguay 5
UZ - Uzbekistan 5
A1 - Anonimo 4
BG - Bulgaria 4
HU - Ungheria 4
JM - Giamaica 4
LT - Lituania 4
PT - Portogallo 4
TW - Taiwan 4
AZ - Azerbaigian 3
LB - Libano 3
MD - Moldavia 3
OM - Oman 3
TN - Tunisia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BH - Bahrain 2
BO - Bolivia 2
BY - Bielorussia 2
CR - Costa Rica 2
ET - Etiopia 2
GA - Gabon 2
KW - Kuwait 2
NP - Nepal 2
RS - Serbia 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BN - Brunei Darussalam 1
BZ - Belize 1
CY - Cipro 1
DO - Repubblica Dominicana 1
GE - Georgia 1
HR - Croazia 1
IS - Islanda 1
KH - Cambogia 1
LI - Liechtenstein 1
LU - Lussemburgo 1
LV - Lettonia 1
ME - Montenegro 1
ML - Mali 1
MN - Mongolia 1
MU - Mauritius 1
Totale 19.443
Salva come PNG Salva come JPEG
Città #
Woodbridge 978
Singapore 966
Ann Arbor 953
Ashburn 745
Houston 716
Fairfield 661
Hong Kong 631
Chandler 605
Jacksonville 450
Dublin 449
Dearborn 369
Wilmington 315
Frankfurt am Main 312
New York 306
Milan 272
Seattle 269
Cambridge 257
Santa Clara 234
Beijing 206
Princeton 199
Dallas 157
Nanjing 138
Shanghai 112
Los Angeles 110
Altamura 95
The Dalles 88
Lawrence 82
Lachine 81
Moscow 66
Hefei 59
Nanchang 58
Council Bluffs 56
Cape Town 55
Dong Ket 55
Vienna 55
Buffalo 54
Columbus 53
Guangzhou 52
Chicago 50
Ho Chi Minh City 50
São Paulo 50
San Diego 48
Shenyang 46
Helsinki 40
Andover 39
Hebei 37
Ottawa 37
Hanoi 36
Munich 33
Rome 33
Tianjin 32
Jinan 29
Seoul 29
Jiaxing 28
Changsha 27
Toronto 26
Boardman 24
Boston 24
Tokyo 23
Zhengzhou 23
Lissone 22
Mountain View 22
Hangzhou 21
Fremont 20
London 20
Manchester 19
Bologna 16
Brooklyn 16
Salt Lake City 15
Brussels 14
Huizen 14
Johannesburg 14
Ningbo 14
Nürnberg 14
Orem 14
Kunming 13
Montreal 13
Norwalk 13
Phoenix 13
Rio de Janeiro 13
Warsaw 13
Belo Horizonte 12
Biên Hòa 11
Istanbul 11
San Francisco 11
Dhaka 10
Haiphong 10
Stockholm 10
Tampa 10
Valencia 10
Ankara 9
Atlanta 9
Brasília 9
Falls Church 9
Guayaquil 9
Jakarta 9
Mexico City 9
Pune 9
Washington 9
Cairo 8
Totale 12.600
Salva come PNG Salva come JPEG
Nome #
Continuous monitoring of cerebral blood flow (CBF) and cerebral temperature in neurocritical care unit 396
Optimising the clinical strategy for autoimmune liver diseases: Principles of value-based medicine 333
Intracerebral hemorrhage in intensive care unit: early prognostication fallacies. A single center retrospective study 306
Trattamento con Sofosbuvir e Ribavirina nei pazienti hcv-positivi listati per il trapianto di fegato: un analisi di costo-efficacia 279
An Effective and Safe Strategy to Target Normothermia in Neurocritical Patients 276
Value-based outcome indicators in the management of hepatocellular carcinoma: Clinical test in a large multicenter study (VBMH study) 275
Health related quality of life in chronic liver diseases 274
Generation and performance of value-based outcome indicators in liver disease: The multicenter V.B.M.H. study 261
High-Resolution Intracranial Pressure Burden and Outcome in Subarachnoid Hemorrhage 260
Outcome indicators in liver cirrhosis: Application of value-based medicine in a large multicenter study (VBMH study) 259
Alcohol consumption and site-specific cancer risk: A comprehensive dose-response meta-analysis 255
P1169 : Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study 253
A noninvasive index of atrial remodeling in patients with paroxysmal and persistent atrial fibrillation: a pilot study 250
Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study 250
P0811 : Sofosbuvir-based direct-acting antivirals treatment for elderly chronic hepatitis C patients: A cost-effectiveness analysis 248
Alcohol drinking and pancreatic cancer risk: a meta-analysis of the dose-risk relation 247
Organ donation after brain death in refractory cardiac arrest treated with extracorporeal CPR 247
Outcome Indicators in Primary Sclerosing Cholangitis: Interim Analysis Of The Value-Based Medicine In Hepatology (VBMH) Study 243
Value-based outcome indicators in liver cirrhosis: validation in a large multicenter study (VBMH study) 241
Characteristics of patients with Chronic Hepatitis C who have failed past treatment or who have never been treated: How much room left for Interferon? 241
The impact of liver disease on the health-related quality of life 241
Random-effects meta-regression models for studying nonlinear dose-response relationship, with an application to alcohol and esophageal squamous cell carcinoma 239
Direct-acting antivirals combination for elderly patients with chronic hepatitis C: A cost-effectiveness analysis 237
Measurement of clinical outcomes and quality of life indicators as a new value-based approach to liver cirrhosis management 233
Generation and Performance of Outcome Indicators in Liver Cirrhosis: The Value Based Medicine in Hepatology Study (V.B.M.H.) 231
Health Related Quality of Life in the Major Liver Conditions 231
The Impact of Type of Liver Conditions on the Patients’ Health Related Quality of Life 226
A Comparison Between The Health-Related Quality Of Life Reported By The General Population And By Patients With Major Liver Diseases 225
Intracranial pressure monitor insertion in traumatic brain injury: a single center, retrospective decision process analysis 225
External Ventricular and Lumbar Drain Device Infections in ICU Patients: A Prospective Multicenter Italian Study 218
Alcohol drinking and risk of renal cell carcinoma: results of a meta-analysis 216
A value-based approach to the management of patients with liver cirrhosis through the systematic measurement of clinical outcome and quality of life indicators 216
Impatto dei farmaci anti virali ad azione diretta sulla cura dei pazienti con epatite C: un approccio di value-based medicine 216
Sofosbuvir-based all-oral treatment for elderly chronic hepatitis C patients: A cost-effectiveness analysis 215
Alcohol drinking and multiple myeloma risk - A systematic review and meta-analysis of the dose-risk relationship 215
Alcohol drinking and laryngeal cancer: Overall and dose-risk relation - A systematic review and meta-analysis 214
Single-Incision Versus Standard Multiple-Incision Laparoscopic Cholecystectomy: A Meta-analysis of Experimental and Observational Studies 213
Alcohol drinking and esophageal squamous cell carcinoma with focus on light-drinkers and never-smokers: A systematic review and meta-analysis 212
Management of treatment-naïve chronic hepatitis C genotype 1 patients: A cost-effectiveness analysis of treatment options 212
Light alcohol drinking and cancer: a meta-analysis 211
Should new antiviral treatments be considered in elderly Chronic Hepatitis C patients? 211
PGI36 Relationship Between Clinical Severity and Health Related Quality of Life in Chronic Liver Diseases 210
Incidence of pain after craniotomy in children 210
A prospective evaluation of short-term and long-term results from colonic stenting for palliation or as a bridge to elective operation versus immediate surgery for large-bowel obstruction 209
Alcohol drinking and colorectal cancer risk: an overall and dose-response meta-analysis of published studies 207
Alcohol drinking and non-Hodgkin lymphoma risk: a systematic review and a meta-analysis 206
Alcohol consumption and lung cancer risk in never smokers: a meta-analysis 204
Value-based approach to hepatocellular carcinoma: outcome indicators tested in a large multicenter study (VBMH study) 204
Should Sofosbuvir-Based All-Oral Treatment Be Considered In Elderly Chronic Hepatitis C Patients? 204
PGI31 Health Care Indicators to Measure Quality of Care in Patients with Liver Diseases 203
Organ donation in cardiac arrest patients treated with extracorporeal CPR: A single centre observational study 203
Difference in health related quality of life of chronic liver diseases and general population 202
Alcohol drinking and epithelial ovarian cancer risk. A systematic review and meta-analysis 201
A meta-analysis on alcohol drinking and esophageal and gastric cardia adenocarcinoma risk 199
A meta-analysis of alcohol drinking and oral and pharyngeal cancers. Part 1: Overall results and dose-risk relation 198
A meta-analysis on alcohol drinking and gastric cancer risk 195
Strong excess risk of pancreatic cancer for low frequency and duration of cigarette smoking: A comprehensive review and meta-analysis 194
The Cost-Effectiveness Of Sofosbuvir And Ribavirin Treatment In Hcv-Infected Patients Listed For Liver Transplantation 193
Alcohol drinking and cutaneous melanoma risk: A systematic review and dose-risk meta-analysis 191
Meta-analysis on incidence of inhibitors in patients with haemophilia A treated with recombinant factor VIII products 191
Trajectories of early secondary insults after traumatic brain injury: a new approach to evaluate impact on outcome 191
Trajectories of early secondary insults correlate to outcomes of traumatic brain injury: results from a large, single centre, observational study 191
A meta-analysis of alcohol drinking and oral and pharyngeal cancers. Part 2: Results by subsites 190
Re: light drinking has positive public health consequences 189
Modelling body mass index and endometrial cancer risk in a pooled-analysis of three case-control studies 187
Incidence of inhibitors to recombinant factor VIII products – A meta-analysis of 1,852 previously untreated patients 186
Alcohol consumption and prostate cancer risk: A meta-analysis of the dose-risk relation 183
Prospective multicentre cohort study evaluating the incidence of pain after craniotomy in children: first interim analysis. 183
Management of chronic hepatitis C (Chc) genotype 1 treatment-naïve patients in an era of rising opportunities and costs: A cost-effectiveness analysis 182
Donor safety in living donor liver donation: An Italian multicenter survey 182
Is multifocality a prognostic factor in childhood hepatoblastoma? 181
A meta-analysis of alcohol consumption and the risk of brain tumours 178
A meta-analysis on alcohol drinking and the risk of Hodgkin lymphoma 176
Applicazione della value-based medicine nella valutazione della cura dei pazienti affetti da epatite. 176
Thromboembolic event rate in patients exposed to anti-inhibitor coagulant complex: a meta-analysis of 40-year published data 172
Management of Chronic hepatitis C (CHC) Genotype 1 treatment-naive patients in an era of rising opportunities and costs - A cost-effectiveness analysis of treatment options 170
A simulation study comparing performance of minimum P-value and Youden index as methods to find optimal cut-points of continuous variables 168
Cost-effectiveness of Sofosbuvir plus Ledipasvir Antiviral Treatment for Elderly Patients with Chronic Hepatitis C Genotype 1 168
A random-effects meta-regression model for studying nonlinear dose-response relationship 164
Finding the optimal cut-point for Gaussian and Gamma distributed biomarkers 162
Factors influencing the decision to monitor intracranial pressure in traumatic brain injury. A large monocentric study 161
Alcohol and liver cancer: a systematic review and meta-analysis of prospective studies 148
Optimal cut-point definition in biomarkers: The case of censored failure time outcome 148
Alcohol drinking and risk of leukemia-A systematic review and meta-analysis of the dose-risk relation 145
Incidence of Thrombo-Embolic Events in Relation to Activated Prothrombin Complex Concentrate Exposure: A Literature Meta-Analysis 144
Sofosbuvir and ribavirinin in HCV-infected patients listed for liver transplantation: A cost-effectiveness analysis 142
Cost-effectiveness of new direct-acting antivirals to prevent post-liver transplant recurrent hepatitis 142
Cut-Point Finding Methods For Continuous Biomarkers In The Presence Of Binary And Censored Failure Time Outcome 139
Safety and Efficacy of Subcutaneous Hepatitis B Immunoprophylaxis using “on demand” Approach: A Single Center Experience 136
Is there a difference in inhibitor incidence with recombinant products? A meta-analysis of 2000 previously untreated patients 136
Cut-pont finding methods for continuous biomarkers 130
Dose-response relationship between cigarette smoking and site-specific cancer risk: Protocol for a systematic review with an original design combining umbrella and traditional reviews 130
Quantifying the Dose-Response Relationship Between Circulating Folate Concentrations and Colorectal Cancer in Cohort Studies: A Meta-Analysis Based on a Flexible Meta-Regression Model 129
Coffee consumption and risk of fractures: A systematic review and dose-response meta-analysis 126
Safety and Efficacy of Subcutaneous Hepatitis B Immunoprophylaxis using" on demand" Approach: A Single Center Experience 120
Cut-point identification in biomarkers for a censored failure time outcome 117
Meta-Analysis on Incidence of Inhibitors in 1,945 Previously Untreated Patients Treated with Recombinant Factor VIII Products: Is There a Difference? 115
Does alcohol consumption increase the risk of cutaneous melanoma? Comments on a recent meta-analysis: reply from the authors 114
Cut-point identification in biomarkers for a censored failure time outcome 114
Totale 19.990
Salva come PNG Salva come JPEG
Categoria #
all - tutte 68.448
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.448
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021695 0 0 0 0 0 75 81 88 103 144 47 157
2021/2022954 40 79 109 98 33 90 29 78 50 84 71 193
2022/20232.189 232 687 171 198 134 338 18 144 178 7 64 18
2023/20241.591 52 69 52 89 174 520 273 75 94 18 16 159
2024/20253.163 227 363 185 127 286 134 164 134 372 448 226 497
2025/20263.599 803 358 586 703 1.009 140 0 0 0 0 0 0
Totale 19.990